- Home
- ABVC vs PPBT Comparison
ABVC vs PPBT Comparison
Compare ABVC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- PPBT
- Stock Information
- Founded
- ABVC 2015
- PPBT 2010
- Country
- ABVC United States
- PPBT Israel
- Employees
- ABVC N/A
- PPBT N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- ABVC Health Care
- PPBT Health Care
- Exchange
- ABVC Nasdaq
- PPBT Nasdaq
- Market Cap
- ABVC 9.9M
- PPBT 8.7M
- IPO Year
- ABVC N/A
- PPBT N/A
- Fundamental
- Price
- ABVC $0.70
- PPBT $3.17
- Analyst Decision
- ABVC
- PPBT Strong Buy
- Analyst Count
- ABVC 0
- PPBT 2
- Target Price
- ABVC N/A
- PPBT $126.50
- AVG Volume (30 Days)
- ABVC 1.2M
- PPBT 23.2K
- Earning Date
- ABVC 03-12-2025
- PPBT 03-07-2025
- Dividend Yield
- ABVC N/A
- PPBT N/A
- EPS Growth
- ABVC N/A
- PPBT N/A
- EPS
- ABVC N/A
- PPBT N/A
- Revenue
- ABVC $509,788.00
- PPBT N/A
- Revenue This Year
- ABVC N/A
- PPBT N/A
- Revenue Next Year
- ABVC N/A
- PPBT N/A
- P/E Ratio
- ABVC N/A
- PPBT N/A
- Revenue Growth
- ABVC N/A
- PPBT N/A
- 52 Week Low
- ABVC $0.40
- PPBT $2.00
- 52 Week High
- ABVC $1.73
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- ABVC 75.66
- PPBT 44.15
- Support Level
- ABVC $0.40
- PPBT $3.01
- Resistance Level
- ABVC $0.88
- PPBT $3.48
- Average True Range (ATR)
- ABVC 0.08
- PPBT 0.22
- MACD
- ABVC 0.02
- PPBT 0.03
- Stochastic Oscillator
- ABVC 62.42
- PPBT 52.63
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.